BREONICS Perfusion Technologies, Inc. is a biomedical research and development company headquartered in Albany, NY. BREONICS’ focus is to apply its novel bioengineering technologies to create innovative medical products for the clinical organ transplant and tissue replacement markets.
Exsanguinous Metabolic Support (EMS) is BREONICS most advanced technology and consists of the solutions and equipment designed to maintain an organ, or a block of vascularized anatomy, off-line from the rest of the physiologic system. EMS is a brake-through technology that provides a number of unique medical applications the first of which will be to provide more human organs for clinical transplantation.
